Rabois Keith

Director Keith Rabois sold 16,088 shares of AFRM for $1,029,091.79 across 5 transactions on 2025-03-03, reducing holdings 20.7%.

Keith Rabois, a director, executed 5 separate sales totaling 16,088 shares for $1,029,091.79 on 2025-03-03, with prices ranging from $61.73 to $66.40 and a blended average of $63.97. This sale reduced his holdings from 77,608 to 61,520 shares, a -20.7% reduction. The timing is notable: the current price of $57.01 is -29.6% from the 52-week high of $80.98 and down -6.6% over the prior 30 days and -20.8% over 90 days, indicating the stock has declined since the transaction. At his same ticker (AFRM), Rabois's 5 prior trades show mixed near-term results, with 30-day returns ranging from -1.3% to -22.4%, and none yet measurable at the 90-day mark. His cross-ticker track record shows 7 prior sells with an average 30-day return of -12.8%, suggesting a pattern of modest downside follow-through post-sale, though the outcome characterization methodology requires full 90-day data for decisive assessment.

Director Keith Rabois sold 16,086 shares of AFRM at blended $62.32 (Jan 2) as stock trades near 52-week high $72.86

Director Keith Rabois executed 3 separate sales totaling 16,086 shares for $1,002,412.56 on 2025-01-02, reducing his holdings by 14.7% to 93,694 shares. The sales occurred at prices of $61.87, $62.51, and $63.41, yielding a blended average of $62.32, while the current price of $66.50 sits 8.7% below the 52-week high of $72.86 and the stock is down 7.6% over the prior 30 days despite a +69.0% gain over 90 days. Rabois has 4 prior sells on record across all tickers with no measurable timing outcomes available yet; this represents his most recent activity at AFRM following three sells on 2024-12-12 (outcomes not yet measurable). The company remains unprofitable with net income of $-100,222,000.00 on revenue of $698,479,000.00, though annual revenue growth stands at +46.3% and market cap is $3,939,418,105.00.

Director Keith Rabois sold 16,086 shares at $68.98–$71.24 for $1.1M on 2024-12-12, reducing stake to 109,780 shares.

Keith Rabois, a director at Affirm Holdings, executed 4 separate sales totaling 16,086 shares for $1,109,656.80 on 2024-12-12, at prices ranging from $68.20 to $71.24 with a blended average of $68.98. This sale reduced his holdings by 12.8% to 109,780 shares post-transaction. The stock's current price of $70.70 sits within the trading range of this transaction, and the company has experienced strong recent momentum (30-day change +29.0%, 90-day change +60.6%), though Affirm remains unprofitable with a net loss of $100.2M in its latest full fiscal year despite revenue growth of 46.3%. The discrete sale execution across multiple price points on a single date provides no direct evidence of timing intent or conviction shifts, given the absence of a prior trading pattern or disclosed plan context.